Excel with Evidera

Upcoming Presentations and Webinars

Our experts attend and participate in scientific, clinical and business meetings around the world. To learn more about an upcoming event or to schedule a meeting, info@evidera.com.

  • Upcoming Webinars

    Webinar

    Quantitative Benefit-Risk Assessment in Drug Development: Identifying and Dealing with Uncertainties

    Presenters: Tommi Tervonen, PhD, Senior Research Associate, Outcomes Research, Evidera
    Wednesday, May 03 2017, 10:00 AM ET

    Coming soon

  • Upcoming Presentations

    • March 24 - 28, 2017
      Canberra, Australia

      Oral Presentation

      Bronchodilator Therapy and Exercise Added to Self-Management Behaviour-Modification: Effects on Physical Activity in COPD

      Authors/Presenters: Troosters T, Maltais F, Leidy N, Lavoie K, Sedeno M, Janssens W, Hamilton A, Erzen D, De Sousa D, Korducki L, Bourbeau J

      Oral Presentation

      Effect of Tiotropium and Olodaterol, Alone and with Exercise Training, on Exercise Endurance in COPD

      Authors/Presenters: Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, De Sousa D, Korducki L, Janssens W, Hamilton A

    • March 27 - 30, 2017
      Denver, CO, USA

      Poster

      The Burden of Severe Hyopglycemia in Type 1 Diabetes

      Authors/Presenters: Liu J, Wang R, Ganz ML, Paprocki Y, Weatherall J

      Poster

      The Burden of Severe Hypoglycemia in Type 2 Diabetes

      Authors/Presenters: Liu J, Wang R, Ganz ML, Paprocki Y, Weatherall J

    • April 27 - 29, 2017
      Montreal, Quebec, Canada

      Poster

      Effect of 8 and 12 Weeks’ Once-Daily Tiotropium and Olodaterol, Alone and Combined with Exercise Training, on Exercise Endurance during Walking in Patients with COPD

      Authors/Presenters: Troosters T, Bourbeau J, Maltais F, Leidy N, Erzen D, De Sousa D, Korducki L, Janssens W, Hamilton A

    • May 6 - 9, 2017
      San Francisco, CA, UsA

      Poster

      Prevalence of Long-Term Neurodevelopmental Impairment Associated with Extreme Prematurity in North America: A Systematic Literature Review

      Authors/Presenters: Sarri G, Abogunrin S, Siffel C, Sarda SP

    • May 10 - 12, 2017
      Bordeaux, France

      Session Speaker

      The Use of DICE Simulation for Epidemiologic Models

      Authors/Presenters: Caro JJ

    • May 19 - 24, 2017
      Washington, DC, USA

      Poster

      The Short-Term Impact of Symptom-Defined COPD Exacerbation Recovery on Health Status and Lung Function

      Authors/Presenters: Murray L, Leidy NK

      Oral Presentation

      EXACT-PRO and Measuring Exacerbations in COPD

      Authors/Presenters: Murray L

    • May 20 - 24, 2017
      San Diego, CA, USA

      Poster

      Early vs. Later Treatment Response in Lurasidone-Treated Patients with Bipolar Depression: Association with Patient-Reported Health Outcomes

      Authors/Presenters: Ng-Mak D, Bacci ED, Poon JL, Rajagopalan K, Loebel A

    • May 20 - 24, 2017
      Boston, MA, USA

      Short Course

      Using DICE Simulation for Health Economic Analyses

      Authors/Presenters: Caro JJ, Moller J

      Short Course

      Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications

      Authors/Presenters: IJzerman MJ, Marsh K, Devlin N

      Workshop

      W3: Developing Cost-Effectiveness Models to Assess Value of Immuno-Oncology Therapies: Challenges and Approaches

      Authors/Presenters: Briggs A, Haddad R, Muszbek N, Zhang Y

      Workshop

      W11: Stated Preferences in Drug Evaluation: A Comparative Assessment of the Use of Stated Preference in the United States, Canada, and the European Union

      Authors/Presenters: Muhlbacher AC, Marsh K, Johnson FR, Marshall D

      Workshop

      W13: ISPOR Clinical Outcome Assessment Measurement in Rare Disease Clinical Trials Emerging Good Practices Task Force - A Case Study on Application of Final Recommendations

      Authors/Presenters: Patrick DL, Perfetto EM, Benjamin K, Vernon MK

      Issue Panel

      IP5: Voices and Echos: What Methods Should We Be Using to Capture the Patient Voice?

      Authors/Presenters: Hamed A, Marsh K, Gwaltney C, Bridges JFP

      Issue Panel

      IP20: Valuing Precision: How Will Next Generation Diagnostics Change the Landscape for HEOR and Patient Management?

      Authors/Presenters: Faulkner EC, Husereau D, Zah V, Poulios N

      Forum

      F9: Health Economic Modeling in Oncology

      Authors/Presenters: Muszbek N, Benedict A, Wolowacz S

      Podium Presentation

      PP4: Validation of a Questionnaire to Assess Patient Perceptions of Injection Devices for Type 2 Diabetes

      Authors/Presenters: Matza, LS, Stewart, KD, Paczkowski R, Currie BM, Yu R, Coyne KS, Boye KS

      Poster

      PHP272: Reference Groups Used in Pregnancy Exposure Registries: Challenges and Opportunities

      Authors/Presenters: Covington D, Buus R, Blum C

      Poster

      PHP279: REMS Survey Response Rate by Method of Recruitment

      Authors/Presenters: Veley K, Covington D, Sites S, Kinard R

      Poster

      PIN41: Cost-Effectiveness Analysis of First-Line Administration of Tenofovir Alafenamide Fumarate (TAF), a Novel Nucleotide Reverse Transcriptase Inhibitor (NRTI), for the Management of Chronic Hepatitis B (CHB) in the United States (US)

      Authors/Presenters: Dusheiko G, Lim J, Liou I, Tafazzoli A, Deniz B, Saint-Laurent Thibault C, Gordon S, Nguyen MH

      Poster

      PIN51: Evaluation of the Performance Properties of the Influenza Patient-Reported Outcomes Instrument (FLU-PRO) in Patients with Influenza-Like Illness (ILI)

      Authors/Presenters: Powers J, Bacci ED, Leidy NK, Stringer S, Memoli M, et al.

      Poster

      PCN15: Efficacy of Treatments in Children with Relapsed/Refractory Acute Lymphocytic Leukemia (R/R ALL): A Systematic Literature Review and Meta-Analysis

      Authors/Presenters: Martin AL, Thomas SK, Cota M, Hao Y, Zhang Y, Turner M

      Poster

      PCN16: A Bayesian Network Meta-Analysis (NMS) of Therapies for Treatment-Naive Chronic Lymphocytic Leukemia (TN-CLL) Patients Ineligible for Full-Dose Fludarabine Therapy

      Authors/Presenters: Xu Y, Fahrbach K, Dorman E, van Sanden S, Diels J, Cote S, Baculea S

      Poster

      PCN40: A Review of Epidemiology, Prognosis, and Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas (HNSCC)

      Authors/Presenters: Blieden M, Muszbek N, Chaudhary MA, Zhang Y

      Poster

      PCN115: Comparison of Value Evaluations Using Drug Abacus and Traditional Cost-Effectiveness Analysis for an Immuno-Oncology Drug in an Orphan Indication

      Authors/Presenters: Garmo V, Lanitis T, Ambavane A, Kongnakorn T, Phatak H

      Poster

      PCN118: Cost-Effectiveness of Ibrutinib as Frontline Treatment for Adult Patients with Chronic Lymphocytic Leukemia in Belgium

      Authors/Presenters: Smet A, Peng S, Dorman E, Deger K, Sorensen S, Baculae S, Cote S

      Poster

      PCN126: Value Demonstration of Immuno-Oncology Therapies in a Rare Tumor Comparing ASCO, NCCN, and Traditional Cost-Effectiveness Analysis

      Authors/Presenters: Garmo V, Ambavane A, Lanitis T, Kongnakorn T, Phatak H

      Poster

      PCN177: Understanding Key Symptoms, Side Effects and Impacts of HR+ and HER2- Advanced Breast Cancer: Literature Review and Expert Interviews

      Authors/Presenters: Krohe M, Tolley C, Higgins S, Liu Z, Cella D, Revicki D, Small T, Tang D

      Poster

      PCN184: Evaluating Clinically Meaningful Change of the EORTC QLQ-C30 in Patients with NSCLC

      Authors/Presenters: Lenderking WR, Speck RM, Huang JT, Huang H, Kerstein D, Reichmann W, Langer CJ

      Poster

      PGI4: Comparative Efficacy and Safety of Tofacitinib and Biologics as Induction Therapy for Moderately-to-Severely Active Ulcerative Colitis: A Systematic Review and Network Meta-Analysis

      Authors/Presenters: Rubin DT, Ashaye AO, Zhang Y, Xu Y, Fahrbach K, Chen LA, Manuchehri A, Kayhan C, Woolcott JC, Cappelleri JC, Healey P

      Poster

      PND29: The Economic Burden of Agitation in Alzheimer's Disease: A Systematic Literature Review

      Authors/Presenters: Anatchkova M, Brooks A, Swett L, Harty A, Duffy R, Baker R, Hammer-Helmich L, Sanon Aigbogun M

      Poster

      PND41: Comparison of Institutional Placement between Alzheimer's Disease (AD) Patients in Medicaid and Two AD Registries

      Authors/Presenters: Tafazzoli A, Kansal A

      Poster

      PSY32: Budget Impact Analysis of Eliglustat for Treatment of Gaucher Disease Type 1 in the United States

      Authors/Presenters: Nalysnyk L, Sugarman R, Ward A

      Poster

      PSY94: Incorporating Patient Input in Selecting Patient Reported Outcomes Instruments for Clinical Studies in Multiple Myeloma

      Authors/Presenters: Fleming S, Eremenco S, Gleeson S, Brooks A, Chiou CF

      Poster

      PSY135: Systematic Literature Review of the Economic Burden Associated with Diffuse Large B Cell Lymphoma and Follicular Lymphoma

      Authors/Presenters: Galaznik A, Bell J, Huelin R, Hoog M, Bhagnani TD, Guo Y, Stokes ME, Seal B, Shou Y

      Poster

      PSY143: Rare Or Next Competitive Landscape

      Authors/Presenters: Pereira L, Faulkner EC

      Poster

      PCV61: Cost-Effectiveness Analysis of Dabigatran versus Rivaroxaban for Non-Valvular Atrial Fibrillation Using Real-World Evidence in Medicare Beneficiaries

      Authors/Presenters: Peng S, Deger K, Ustyugova AA, Gandhi P, Qiao N, Wang C, Kansal A

      Poster

      PMD110: The Need for Payer Coverage of Large Next Generation Sequencing Panel Testing in Epilepsy: Potential for Missed Diagnoses Using a Small Gene Panel Approach

      Authors/Presenters: Spinner DS, Cardeiro D, Stanley CM, Le NM, Head HA, Scacheri CA, Schuette JL, Pineda-Alvarez DE, Zare AS, Smith D, Faulkner EC

      Poster

      PUK19: Health Economic Assessment of Treatment Sequences for the Management of Patients with Metastatic Renal Cell Carcinoma in the United States

      Authors/Presenters: Doleh, Y, Deniz B, Ambavane A, Rao S, Page V, Michaelson MD

      Poster

      PHS59: Economic Burden of Very Preterm Birth: A Systematic Literature Review

      Authors/Presenters: Sarda SP, Abogunrin S, Zhang Y, Sarri G

      Poster

      PHS79: Utilization And Cost Of Healthcare Services During Episodes Of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Involving Admission To United States (US) Hospitals: A Retrospective Observational Analysis Using A Large Healthcare Claims Database

      Authors/Presenters: Keyloun KR, Murphy B, Gillard P, Berger A

      Poster

      PRM5: Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents: The Re-Kinect Study

      Authors/Presenters: Yeomans K, Lenderking WR, Ross L, Shalhoub H, Yonan C

      Poster

      PRM60: Machine Learning Integration with Molecular Diagnostics: Progress and Potential Pitfalls

      Authors/Presenters: Ringo MC, Faulkner E

      Poster

      PRM87: Exploring Python for Use in Modeling: Decreasing Run-Times for Probabilistic Sensitivity Analysis

      Authors/Presenters: Stokes ME, Quon P

      Poster

      PRM98: Why Isn't It The Norm To Use Normal In PSA?

      Authors/Presenters: Oguz M, Roiz J

      Poster

      PRM135: Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) Among Chronic Pain Patients

      Authors/Presenters: Coyne K, Barsdorf A, Brooks A, Maziere JY, Pierson R, Butler S, Schnoll S

      Poster

      PRM170: Barriers and Solutions for Real-World Chart Review Evidence Generation

      Authors/Presenters: Stein D, Ross L

      Poster

      PRM193: Nuances of Assessing Clinician Agreement in Clinician Reported Outcomes (CLINROS)

      Authors/Presenters: Bender R, Lenderking W

    • May 29 - June 1, 2017
      Montreal, Canada

      Short Course

      EPIB-654 PE IV: Pharmacoeconomics Summer Course

      Authors/Presenters: Caro JJ

    • June 17 - 21, 2017
      Rome, Italy

      Workshop

      Discretely-Integrated Condition Event (DICE) Simulation for Integrated HTA

      Authors/Presenters: Caro JJ, Moller J

      Symposium

      Changing the HTA Paradigm: Beyond Clinical and Economic Evaluation for Innovative Drugs

      Authors/Presenters: Chevrou-Severac H, Caro JJ, Walker A, de Pouvourville G, Formica M

      Issue Panel

      Validation of Health Economic Models: Should We Promote a Pragmatic Approach?

      Authors/Presenters: Caro JJ, Moller J, Ghabri S, Stevenson M, Kolominsky-Rabas P

    • June 18 - 22, 2017
      Chicago, IL, USA

      Chair/Speaker

      Patient-Reported Outcomes (PROs): Hot Topics - Part 2 of 2

      Authors/Presenters: Revicki D

      Speaker

      2.5 Billion Opinions from 50 Million Health Care Users: A Guide to Health-Related Social Media

      Authors/Presenters: Cox A

      Speaker

      An Innovative Patient-Centric Approach to Conducting Postmarketing Safety Studies

      Authors/Presenters: Covington D

      Speaker

      Developing and Evaluating PRO Instruments in Clinical Trials: Risks and Advantages for Applications using Registration Trials

      Authors/Presenters: Revicki D

      Speaker

      Incorporating Patient Preferences in Drug Development and Approval

      Authors/Presenters: Marsh K

      Speaker

      Lessons Learned From the EMA Adaptive Pathways Pilot Project: The Need for a Real-world Data Strategy for Success

      Authors/Presenters: Lambrelli D

      Speaker

      Take-Home Learnings on Do's and Dont's on the Planning and Conduct of a PASS

      Authors/Presenters: Cid J

    • September 15 - 17, 2017
      Sao Paulo, Brazil

      Short Course

      Modelación Aplicada (Applied Modeling)

      Authors/Presenters: Caro JJ

Back to Top